FDA grants MIMvista clearance

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Dec. 5 – MIMvista received FDA 510(k) clearance for automatic deformable contouring and RT-PACS with the release of MIM 4.1, which was announced at the 93rd scientific assembly and annual meeting of the Radiological Society of North America (RSNA) in Chicago last week.

MIM 4.1, the latest software release from MIMvista Corp., offers new tools for radiation oncology, radiology and nuclear medicine. MIMcontouring Advanced provides automatic atlas-based deformable contouring and adaptive re-contouring using MIMvista’s VoxAlign Deformation Engine for initial contour generation of entire structure sets and quick re-planning making adaptive radiation therapy practical.

MIMpacs leverages existing MIMvista display software to create an image-centric RT-PACS solution handling traditional modalities and DICOM RT formats. Therapy response tools include automatic registration, PET tumor segmentation, contour propagation and RECIST/WHO calculations across time points. Workflows can be created for virtually any analysis, treatment or research application to automate multi-step processes in MIM.

MIM Extensions provides a programming interface for customizable functionalities developed in IDL (ITT Visual Information Solutions) for distribution to clinical MIM users.